U.S. market Open. Closes in 35 minutes

TARA | Protara Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/A2.95M
Cost of Revenue341.00K247.00K1.17M196.00K16.00KN/AN/AN/AN/AN/A
Gross Profit-341.00K-247.00K-1.17M-196.00K-16.00KN/AN/AN/AN/AN/A
Operating Expenses43.61M37.55M47.49M34.44M15.25M26.08M30.36M28.70M20.87M10.53M
Selling, General & Admin18.62M20.74M26.40M22.46M8.82M10.57M8.68M9.84M8.49M4.10M
Research & Development24.99M16.81M21.09M11.98M6.44M15.51M21.69M18.87M12.38M6.43M
Other Operating Expenses-204.00K29.52MN/AN/AN/A207.00KN/AN/AN/AN/A
Operating Income-43.61M-67.06M-47.49M-34.44M-15.25M-26.08M-30.36M-28.70M-20.87M-7.58M
Other Expenses / Income3.19M1.11M237.00K466.00K262.00K643.00K398.00K179.00K-507.00K4.24M
Before Tax Income-40.42M-65.95M-47.25M-33.98M-14.99M-25.44M-29.96M-28.53M-21.38M-3.34M
Income Tax Expenses-341.00K-1.14M-117.00K-466.00K-262.00K5.35MN/AN/AN/AN/A
Net Income-40.42M-64.81M-47.13M-33.51M-14.73M-25.44M-29.96M-28.53M-21.38M-3.34M
Interest ExpensesN/A1.14M1.74M34.00KN/AN/A259.00K193.00K144.00K857.00K
Basic Shares Outstanding11.33M11.26M11.23M7.23M64.44K2.56M431.86K414.04K411.60K76.61K
Diluted Shares Outstanding11.33M11.26M11.23M7.23M64.44K2.56M431.86K414.04K411.60K76.61K
EBITDA-43.27M-8.03M-47.25M-34.25M-15.24M-26.40M-29.56M-28.58M-20.81M-2.46M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-83.28%
EBIT-40.76M-64.81M-45.52M-33.94M-14.99M-20.09M-29.70M-28.33M-21.23M-2.48M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-84.29%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙